These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35285136)
41. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56 Tang Y; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z Biomed Res Int; 2019; 2019():2582401. PubMed ID: 31641668 [TBL] [Abstract][Full Text] [Related]
42. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148 [TBL] [Abstract][Full Text] [Related]
43. Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress. Thompson SM; Callstrom MR; Jondal DE; Butters KA; Knudsen BE; Anderson JL; Lien KR; Sutor SL; Lee JS; Thorgeirsson SS; Grande JP; Roberts LR; Woodrum DA PLoS One; 2016; 11(9):e0162634. PubMed ID: 27611696 [TBL] [Abstract][Full Text] [Related]
44. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling. Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F mBio; 2019 Feb; 10(1):. PubMed ID: 30755508 [TBL] [Abstract][Full Text] [Related]
45. HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. Jin YP; Valenzuela NM; Zhang X; Rozengurt E; Reed EF J Immunol; 2018 Apr; 200(7):2372-2390. PubMed ID: 29475988 [TBL] [Abstract][Full Text] [Related]
46. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation. Streets AJ; Wessely O; Peters DJ; Ong AC Hum Mol Genet; 2013 May; 22(10):1924-39. PubMed ID: 23390129 [TBL] [Abstract][Full Text] [Related]
47. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
48. Polycystin-1 protein level determines activity of the Galpha12/JNK apoptosis pathway. Yu W; Kong T; Beaudry S; Tran M; Negoro H; Yanamadala V; Denker BM J Biol Chem; 2010 Apr; 285(14):10243-51. PubMed ID: 20106977 [TBL] [Abstract][Full Text] [Related]
49. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Li J; You T; Jing J Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182 [TBL] [Abstract][Full Text] [Related]
50. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes. Weinberg MA Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392 [TBL] [Abstract][Full Text] [Related]
51. Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. Aguiari G; Trimi V; Bogo M; Mangolini A; Szabadkai G; Pinton P; Witzgall R; Harris PC; Borea PA; Rizzuto R; del Senno L Cell Prolif; 2008 Jun; 41(3):554-73. PubMed ID: 18422703 [TBL] [Abstract][Full Text] [Related]
52. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. Teng P; Jiao Y; Hao M; Tang X J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322 [TBL] [Abstract][Full Text] [Related]
53. Regulation of Polycystin-1 Function by Calmodulin Binding. Doerr N; Wang Y; Kipp KR; Liu G; Benza JJ; Pletnev V; Pavlov TS; Staruschenko A; Mohieldin AM; Takahashi M; Nauli SM; Weimbs T PLoS One; 2016; 11(8):e0161525. PubMed ID: 27560828 [TBL] [Abstract][Full Text] [Related]
54. Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis. Behr B; Longaker MT; Quarto N Dev Biol; 2010 Aug; 344(2):922-40. PubMed ID: 20547147 [TBL] [Abstract][Full Text] [Related]
55. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
56. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. Woodward OM; Li Y; Yu S; Greenwell P; Wodarczyk C; Boletta A; Guggino WB; Qian F PLoS One; 2010 Aug; 5(8):e12305. PubMed ID: 20808796 [TBL] [Abstract][Full Text] [Related]
57. Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. Li Y; Santoso NG; Yu S; Woodward OM; Qian F; Guggino WB J Biol Chem; 2009 Dec; 284(52):36431-36441. PubMed ID: 19854836 [TBL] [Abstract][Full Text] [Related]
58. Ras, PI3K and mTORC2 - three's a crowd? Smith SF; Collins SE; Charest PG J Cell Sci; 2020 Oct; 133(19):. PubMed ID: 33033115 [TBL] [Abstract][Full Text] [Related]
59. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. Nakao T; Shiota M; Tatemoto Y; Izumi Y; Iwao H J Pharmacol Sci; 2007 Dec; 105(4):334-41. PubMed ID: 18057776 [TBL] [Abstract][Full Text] [Related]
60. The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium. Margaria JP; Campa CC; De Santis MC; Hirsch E; Franco I Cell Signal; 2020 Feb; 66():109468. PubMed ID: 31715259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]